Magnesium intake is inversely associated with risk of non-alcoholic fatty liver disease among American adults (original) (raw)

References

1. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64:73–84. https://doi.org/10.1002/hep.28431
   Article PubMed Google Scholar
2. Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, Srishord M (2011) Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 9:524–530. https://doi.org/10.1016/j.cgh.2011.03.020
   Article PubMed Google Scholar
3. Younossi ZM, Otgonsuren M, Henry L, Venkatesan C, Mishra A, Erario M, Hunt S (2015) Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. Hepatology 62:1723–1730. https://doi.org/10.1002/hep.28123
   Article CAS PubMed Google Scholar
4. Younossi Z, Stepanova M, Ong JP, Jacobson IM, Bugianesi E, Duseja A, Eguchi Y, Wong VW, Negro F, Yilmaz Y, Romero-Gomez M, George J, Ahmed A, Wong R, Younossi I, Ziayee M, Afendy A (2019) Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates. Clin Gastroenterol Hepatol 17:748-755.e3. https://doi.org/10.1016/j.cgh.2018.05.057
   Article PubMed Google Scholar
5. Patrick L (2002) Nonalcoholic fatty liver disease: relationship to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine. Altern Med Rev 7:276–291
   PubMed Google Scholar
6. Birkenfeld AL, Shulman GI (2014) Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology 59:713–723. https://doi.org/10.1002/hep.26672
   Article PubMed Google Scholar
7. Kandeel FR, Balon E, Scott S, Nadler JL (1996) Magnesium deficiency and glucose metabolism in rat adipocytes. Metabolism 45:838–843. https://doi.org/10.1016/S0026-0495(96)90156-0
   Article CAS PubMed Google Scholar
8. Balon TW, Gu JL, Tokuyama Y, Jasman AP, Nadler JL (1995) Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM. Am J Physiol 269:E745-752. https://doi.org/10.1152/ajpendo.1995.269.4.E745
   Article CAS PubMed Google Scholar
9. Morais JBS, Severo JS, de Alencar GRR, de Oliveira ARS, Cruz KJC, Marreiro DDN, Freitas B, de Carvalho CMR, Martins M, Frota KMG (2017) Effect of magnesium supplementation on insulin resistance in humans: a systematic review. Nutrition 38:54–60. https://doi.org/10.1016/j.nut.2017.01.009
   Article CAS PubMed Google Scholar
10. Sohrabipour S, Sharifi MR, Sharifi M, Talebi A, Soltani N (2018) Effect of magnesium sulfate administration to improve insulin resistance in type 2 diabetes animal model: using the hyperinsulinemic-euglycemic clamp technique. Fundam Clin Pharmacol 32:603–616. https://doi.org/10.1111/fcp.12387
    Article CAS PubMed Google Scholar
11. Freedman AM, Mak IT, Stafford RE, Dickens BF, Cassidy MM, Muesing RA, Weglicki WB (1992) Erythrocytes from magnesium-deficient hamsters display an enhanced susceptibility to oxidative stress. Am J Physiol 262:C1371-1375. https://doi.org/10.1152/ajpcell.1992.262.6.C1371
    Article CAS PubMed Google Scholar
12. Nielsen FH (2018) Magnesium deficiency and increased inflammation: current perspectives. J Inflamm Res 11:25–34. https://doi.org/10.2147/jir.S136742
    Article CAS PubMed PubMed Central Google Scholar
13. Li W, Zhu X, Song Y, Fan L, Wu L, Kabagambe EK, Hou L, Shrubsole MJ, Liu J, Dai Q (2018) Intakes of magnesium, calcium and risk of fatty liver disease and prediabetes. Public Health Nutr 21:2088–2095. https://doi.org/10.1017/S1368980018000642
    Article PubMed PubMed Central Google Scholar
14. Eshraghian A, Nikeghbalian S, Geramizadeh B, Malek-Hosseini SA (2018) Serum magnesium concentration is independently associated with non-alcoholic fatty liver and non-alcoholic steatohepatitis. United Eur Gastroenterol J 6:97–103. https://doi.org/10.1177/2050640617707863
    Article CAS Google Scholar
15. Rosanoff A, Weaver CM, Rude RK (2012) Suboptimal magnesium status in the United States: are the health consequences underestimated? Nutr Rev 70:153–164. https://doi.org/10.1111/j.1753-4887.2011.00465.x
    Article PubMed Google Scholar
16. Friedman GD, Cutter GR, Donahue RP, Hughes GH, Hulley SB, Jacobs DR Jr, Liu K, Savage PJ (1988) CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 41:1105–1116. https://doi.org/10.1016/0895-4356(88)90080-7
    Article CAS PubMed Google Scholar
17. McDonald A, Van Horn L, Slattery M, Hilner J, Bragg C, Caan B, Jacobs D Jr, Liu K, Hubert H, Gernhofer N, Betz E, Havlik D (1991) The CARDIA dietary history: development, implementation, and evaluation. J Am Diet Assoc 91:1104–1112
    Article CAS Google Scholar
18. Liu K, Slattery M, Jacobs D Jr, Cutter G, McDonald A, Van Horn L, Hilner JE, Caan B, Bragg C, Dyer A et al (1994) A study of the reliability and comparative validity of the cardia dietary history. Ethn Dis 4:15–27
    CAS PubMed Google Scholar
19. He K, Song Y, Belin RJ, Chen Y (2006) Magnesium intake and the metabolic syndrome: epidemiologic evidence to date. J Cardiometab Syndr 1:351–355. https://doi.org/10.1111/j.1559-4564.2006.05702.x
    Article PubMed Google Scholar
20. He K, Liu K, Daviglus ML, Morris SJ, Loria CM, Van Horn L, Jacobs DR, Savage PJ (2006) Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 113:1675–1682. https://doi.org/10.1161/CIRCULATIONAHA.105.588327
    Article CAS PubMed Google Scholar
21. Hu FB, Stampfer MJ, Rimm E, Ascherio A, Rosner BA, Spiegelman D, Willett WC (1999) Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol 149:531–540. https://doi.org/10.1093/oxfordjournals.aje.a009849
    Article CAS PubMed Google Scholar
22. Sijtsma FP, Meyer KA, Steffen LM, Shikany JM, Van Horn L, Harnack L, Kromhout D, Jacobs DR Jr (2012) Longitudinal trends in diet and effects of sex, race, and education on dietary quality score change: the coronary artery risk development in young adults study. Am J Clin Nutr 95:580–586. https://doi.org/10.3945/ajcn.111.020719
    Article CAS PubMed PubMed Central Google Scholar
23. VanWagner LB, Khan SS, Ning H, Siddique J, Lewis CE, Carr JJ, Vos MB, Speliotes E, Terrault NA, Rinella ME, Lloyd-Jones DM, Allen NB (2018) Body mass index trajectories in young adulthood predict non-alcoholic fatty liver disease in middle age: the CARDIA cohort study. Liver Int 38:706–714. https://doi.org/10.1111/liv.13603
    Article PubMed Google Scholar
24. VanWagner LB, Ning H, Lewis CE, Shay CM, Wilkins J, Carr JJ, Terry JG, Lloyd-Jones DM, Jacobs DR Jr, Carnethon MR (2014) Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the coronary artery risk development in young adults study. Atherosclerosis 235:599–605. https://doi.org/10.1016/j.atherosclerosis.2014.05.962
    Article CAS PubMed PubMed Central Google Scholar
25. VanWagner LB, Terry JG, Chow LS, Alman AC, Kang H, Ingram KH, Shay C, Lewis CE, Bryan RN, Launer LJ, Jeffrey Carr J (2017) Nonalcoholic fatty liver disease and measures of early brain health in middle-aged adults: the CARDIA study. Obesity 25:642–651. https://doi.org/10.1002/oby.21767
    Article CAS PubMed Google Scholar
26. VanWagner LB, Ning H, Allen NB, Ajmera V, Lewis CE, Carr JJ, Lloyd-Jones DM, Terrault NA, Siddique J (2017) Alcohol use and cardiovascular disease risk in patients with nonalcoholic fatty liver disease. Gastroenterology 153:1260-1272.e3. https://doi.org/10.1053/j.gastro.2017.08.012
    Article CAS PubMed Google Scholar
27. Kodama Y, Ng CS, Wu TT, Ayers GD, Curley SA, Abdalla EK, Vauthey JN, Charnsangavej C (2007) Comparison of CT methods for determining the fat content of the liver. Am J Roentgenol 188:1307–1312. https://doi.org/10.2214/ajr.06.0992
    Article Google Scholar
28. Zeng MD, Fan JG, Lu LG, Li YM, Chen CW, Wang BY, Mao YM (2008) Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases. J Dig Dis 9:108–112. https://doi.org/10.1111/j.1751-2980.2008.00331.x
    Article PubMed Google Scholar
29. Schreiner PJ, Jacobs DR Jr, Wong ND, Kiefe CI (2016) Twenty-five year secular trends in lipids and modifiable risk factors in a population-based biracial cohort: the coronary artery risk development in young adults (CARDIA) study, 1985–2011. J Am Heart Assoc 5:e003384. https://doi.org/10.1161/JAHA.116.003384
    Article PubMed PubMed Central Google Scholar
30. Jacobs DR Jr, Hahn LP, Haskell WL, Pirie P, Sidney S (1989) Validity and reliability of short physical activity history: cardia and the minnesota heart health program. J Cardiopulm Rehabil 9:448–459
    Article Google Scholar
31. Reis JP, Allen N, Gunderson EP, Lee JM, Lewis CE, Loria CM, Powell-Wiley TM, Rana JS, Sidney S, Wei G (2015) Excess body mass index-and waist circumference-years and incident cardiovascular disease: the CARDIA study. Obesity 23:879–885. https://doi.org/10.1002/oby.21023
    Article PubMed Google Scholar
32. Herbert V, Lau KS, Gottlieb CW, Bleicher SJ (1965) Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375–1384. https://doi.org/10.1210/jcem-25-10-1375
    Article CAS PubMed Google Scholar
33. Bancks MP, Carnethon MR, Jacobs DR, Launer LJ, Reis JP, Schreiner PJ, Shah RV, Sidney S, Yaffe K, Yano Y (2018) Fasting glucose variability in young adulthood and cognitive function in middle age: the coronary artery risk development in young adults (CARDIA) study. Diabetes Care 41:2579–2585. https://doi.org/10.2337/dc18-1287
    Article PubMed PubMed Central Google Scholar
34. Warnick GR (1986) Enzymatic methods for quantification of lipoprotein lipids. Methods Enzymol 129:101–123. https://doi.org/10.1016/0076-6879(86)29064-3
    Article CAS PubMed Google Scholar
35. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502. https://doi.org/10.1093/clinchem/18.6.499
    Article CAS Google Scholar
36. Cantero I, Abete I, Monreal JI, Martinez JA, Zulet MA (2017) Fruit fiber consumption specifically improves liver health status in obese subjects under energy restriction. Nutrients 9:667. https://doi.org/10.3390/nu9070667
    Article CAS PubMed Central Google Scholar
37. Leamy AK, Egnatchik RA, Young JD (2013) Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease. Prog Lipid Res 52:165–174. https://doi.org/10.1016/j.plipres.2012.10.004
    Article CAS PubMed Google Scholar
38. Fan JG, Cao HX (2013) Role of diet and nutritional management in non-alcoholic fatty liver disease. J Gastroenterol Hepatol 28(Suppl):81–87. https://doi.org/10.1111/jgh.12244
    Article CAS PubMed Google Scholar
39. Pacana T, Sanyal AJ (2012) Vitamin E and non-alcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care 15:641–648. https://doi.org/10.1097/MCO.0b013e328357f747
    Article CAS PubMed PubMed Central Google Scholar
40. Chiu S, Mulligan K, Schwarz J-M (2018) Dietary carbohydrates and fatty liver disease: de novo lipogenesis. Curr Opin Clin Nutr Metab Care 21:277–282. https://doi.org/10.1097/MCO.0000000000000469
    Article CAS PubMed Google Scholar
41. van Dam RM, Hu FB, Rosenberg L, Krishnan S, Palmer JR (2006) Dietary calcium and magnesium, major food sources, and risk of type 2 diabetes in US black women. Diabetes Care 29:2238–2243. https://doi.org/10.2337/dc06-1014
    Article CAS PubMed Google Scholar
42. Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference (1997) The national academies collection: reports funded by national institutes of health. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. National Academies Press, Washington (DC), pp 190–249
    Google Scholar
43. Wong VW, Chan WK, Chitturi S, Chawla Y, Dan YY, Duseja A, Fan J, Goh KL, Hamaguchi M, Hashimoto E, Kim SU, Lesmana LA, Lin YC, Liu CJ, Ni YH, Sollano J, Wong SK, Wong GL, Chan HL, Farrell G (2018) Asia-pacific working party on non-alcoholic fatty liver disease guidelines 2017-part 1: definition, risk factors and assessment. J Gastroenterol Hepatol 33:70–85. https://doi.org/10.1111/jgh.13857
    Article PubMed Google Scholar
44. Kostov K (2019) Effects of magnesium deficiency on mechanisms of insulin resistance in type 2 diabetes: focusing on the processes of insulin secretion and signaling. Int J Mol Sci 20:1351. https://doi.org/10.3390/ijms20061351
    Article CAS PubMed Central Google Scholar
45. Simental-Mendia LE, Sahebkar A, Rodriguez-Moran M, Guerrero-Romero F (2016) A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control. Pharmacol Res 111:272–282. https://doi.org/10.1016/j.phrs.2016.06.019
    Article CAS PubMed Google Scholar
46. Morais JB, Severo JS, Santos LR, de Sousa Melo SR, de Oliveira Santos R, de Oliveira AR, Cruz KJ, do Nascimento Marreiro D (2017) Role of magnesium in oxidative stress in individuals with obesity. Biol Trace Elem Res 176:20–26. https://doi.org/10.1007/s12011-016-0793-1
    Article CAS PubMed Google Scholar
47. Afanas’ev IB, Suslova TB, Cheremisina ZP, Abramova NE, Korkina LG (1995) Study of antioxidant properties of metal aspartates. Analyst 120:859–862. https://doi.org/10.1039/AN9952000859
    Article CAS PubMed Google Scholar
48. Poongothai A, Vishnupriya S, Ragunadharao D (2004) Quantitative variation of superoxide dismutase levels in leukaemias. Indian J Hum Genet 10:9–12
    CAS Google Scholar
49. Mahalle N, Garg MK, Mv K, Naik S (2014) Relation of magnesium with insulin resistance and inflammatory markers in subjects with known coronary artery disease. J Cardiovasc Dis Res 5:22–29. https://doi.org/10.5530/jcdr.2014.1.4
    Article CAS Google Scholar
50. Kim DJ, Xun P, Liu K, Loria C, Yokota K, Jacobs DR Jr, He K (2010) Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes. Diabetes Care 33:2604–2610. https://doi.org/10.2337/dc10-0994
    Article CAS PubMed PubMed Central Google Scholar
51. Chacko SA, Song Y, Nathan L, Tinker L, de Boer IH, Tylavsky F, Wallace R, Liu S (2010) Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women. Diabetes Care 33:304–310. https://doi.org/10.2337/dc09-1402
    Article CAS PubMed Google Scholar
52. Lu L, Chen C, Yang K, Zhu J, Xun P, Shikany JM, He K (2020) Magnesium intake is inversely associated with risk of obesity in a 30-year prospective follow-up study among American young adults. Eur J Nutr 59:3745–3753. https://doi.org/10.1007/s00394-020-02206-3
    Article CAS PubMed PubMed Central Google Scholar
53. Spengler EK, Loomba R (2015) Recommendations for diagnosis, referral for liver biopsy, and treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Mayo Clin Proc 90:1233–1246. https://doi.org/10.1016/j.mayocp.2015.06.013
    Article PubMed Google Scholar
54. Dorosti M, Heidarloo AJ, Bakhshimoghaddam F, Alizadeh M (2020) Whole-grain consumption and its effects on hepatic steatosis and liver enzymes in patients with non-alcoholic fatty liver disease: a randomised controlled clinical trial. Br J Nutr 123:328–336. https://doi.org/10.1017/S0007114519002769
    Article CAS PubMed Google Scholar
55. Lazo M, Hernaez R, Eberhardt MS, Bonekamp S, Kamel I, Guallar E, Koteish A, Brancati FL, Clark JM (2013) Prevalence of nonalcoholic fatty liver disease in the United States: the third national health and nutrition examination survey, 1988–1994. Am J Epidemiol 178:38–45. https://doi.org/10.1093/aje/kws448
    Article PubMed PubMed Central Google Scholar
56. Blais P, Husain N, Kramer JR, Kowalkowski M, El-Serag H, Kanwal F (2015) Nonalcoholic fatty liver disease is underrecognized in the primary care setting. Am J Gastroenterol 110:10–14. https://doi.org/10.1038/ajg.2014.134
    Article CAS PubMed Google Scholar
57. Bae JC, Lee WY, Yoon KH, Park JY, Son HS, Han KA, Lee KW, Woo JT, Ju YC, Lee WJ, Cho YY, Lee MK (2015) Improvement of nonalcoholic fatty liver disease with carnitine-orotate complex in type 2 diabetes (CORONA): a randomized controlled trial. Diabetes Care 38:1245–1252. https://doi.org/10.2337/dc14-2852
    Article CAS PubMed Google Scholar
58. Foster T, Budoff MJ, Saab S, Ahmadi N, Gordon C, Guerci AD (2011) Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis heart study randomized clinical trial. Am J Gastroenterol 106:71–77. https://doi.org/10.1038/ajg.2010.299
    Article CAS PubMed Google Scholar
59. Yang Y, Zhao X, Xu H, Wang S, Pan Y, Wang S, Xu Q, Jiao R, Gu H, Kong L (2019) Magnesium isoglycyrrhizinate ameliorates high fructose-induced liver fibrosis in rat by increasing miR-375-3p to suppress JAK2/STAT3 pathway and TGF-β1/Smad signaling. Acta Pharmacol Sin 40:879–894. https://doi.org/10.1038/s41401-018-0194-4
    Article CAS PubMed Google Scholar

Download references